Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

PLX holding history

Protalix BioTherapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PLX overviewAll 13F holders of PLXFull Q2 2026 holdings

Shares (Q2 2026)
1,096,000
Value
$2.55M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of PLX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,096,000$2.55M<0.1%−128,800−10.5%ReducedHolders
Q1 20261,224,800$2.66M<0.1%−38,500−3.0%ReducedHolders
Q4 20251,263,300$2.27M<0.1%−52,100−4.0%ReducedHolders
Q3 20251,315,400$2.92M<0.1%−299,603−18.6%ReducedHolders
Q2 20251,615,003$2.39M<0.1%+426,050+35.8%AddedHolders
Q1 20251,188,953$3.04M<0.1%+70,953+6.3%AddedHolders
Q4 20241,118,000$2.10M<0.1%+162,100+17.0%AddedHolders
Q3 2024955,900$975.0K<0.1%+151,300+18.8%AddedHolders
Q2 2024804,600$941.4K<0.1%−20,100−2.4%ReducedHolders
Q1 2024824,700$1.04M<0.1%+159,100+23.9%AddedHolders
Q4 2023665,600$1.19M<0.1%+44,500+7.2%AddedHolders
Q3 2023621,100$1.03M<0.1%−38,200−5.8%ReducedHolders
Q2 2023659,300$1.32M<0.1%−550,450−45.5%ReducedHolders
Q1 20231,209,750$2.54M<0.1%+985,147+438.6%AddedHolders
Q4 2022224,603$308.0K<0.1%+107,403+91.6%AddedHolders
Q3 2022117,200$122.0K<0.1%+2,400+2.1%AddedHolders
Q2 2022114,800$125.0K<0.1%+102,900+864.7%AddedHolders
Q1 202211,900$13.0K<0.1%+11,900NewHolders
Q3 20210$00.0%−30,075−100.0%Sold outHolders
Q2 202130,075$57.0K<0.1%−477,559−94.1%ReducedHolders
Q1 2021507,634$2.26M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.